Head and neck cancer: Gene therapy approaches. Part 1: Adenoviral vectors

By Nemunaitis John   O'Brien John  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 177-185

Informa Healthcare

Access to resources Recommend Favorite

Use of suicide genes for cancer gene therapy: study of the different approaches

By Vassaux G   Martin-Duque P  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 4, 2004-04 ,pp. : 519-530

Informa Healthcare

Access to resources Recommend Favorite

Polymorphisms in DNA damage response genes and head and neck cancer risk

By Flores-Obando Rafael E.   Gollin Susanne M.   Ragin Camille C.  

Biomarkers, Vol. 15, Iss. 5, 2010-08 ,pp. : 379-399

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer

By Kyula Joan N   Roulstone Victoria   Karapanagiotou Eleni M   Melcher Alan A   Harrington Kevin J  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite

Zalutumumab in head and neck cancer

By Schick Ulrike   Gujral Dorothy M   Richards Tom M   Harrington Kevin J   Nutting Christopher M  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite